Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006
Effect of age, gender, severity and smoking status on rate of decline of FEV1 in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 517s Year: 2005
The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002
Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Roflumilast, an oral, once-daily PDE4 inhibitor, improves lung function and reduces exacerbation rates in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 21s Year: 2004
COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Quality of life of smokers depending on age, smoking history and COPD symptoms Source: Annual Congress 2007 - Smoking and COPD Year: 2007
Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
Relationship between age, sex, duration of asthma, asthma severity and deterioration of lung function in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 33s Year: 2001
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Source: Eur Respir J 2004; 23: 464-476 Year: 2004
The respiration status in smokers with chronic bronchitis during smoking cessation period Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002
The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001
Evidence for the onset of COPD in childhood, and the role of genetics Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence Year: 2005
Effects of exposure to parental smoking on pulmonary function and symptoms in children with asthma Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma Year: 2011
Are symptoms of chronic bronchitis and sputum inflammatory cell counts related to the duration of smoking cessation in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 45s Year: 2004
Developing COPD – a 25 year follow-up study of the general population Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005
Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009